Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Intarcia Therapeutics
>
Intarcia Therapeutics
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5990527"]Few anecdotal facts to point out why ITCA will fail once it gets approved (that is big when) and commercialized:</p><p><br /></p><p>1. Bayer's Viadur pump was not only a dud but in rather crowded prostate cancer drugs and treatments space like Type 2 diabetes </p><p>2. Viadur was not selling and there came a point Bayer had to stop bleeding money selling this unpopular treatment not to mention stuck with expiring pumps</p><p>3. Add to this creeping manufacturing cost and the clincher - <b>limited long-term market viability</b></p><p>4. Onc docs are not surgeons like endocrinologist and primary care docs</p><p>5. Difference however may be that onc drugs can sell for premium vs. generic GLP1 drugs</p><p><br /></p><p><a href="https://www.fiercebiotech.com/biotech/marketing-of-viadur-r-leuprolide-acetate-implant-to-phase-out-by-april-2008" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.fiercebiotech.com/biotech/marketing-of-viadur-r-leuprolide-acetate-implant-to-phase-out-by-april-2008" rel="nofollow">https://www.fiercebiotech.com/biotech/marketing-of-viadur-r-leuprolide-acetate-implant-to-phase-out-by-april-2008</a>[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5990527"]Few anecdotal facts to point out why ITCA will fail once it gets approved (that is big when) and commercialized: 1. Bayer's Viadur pump was not only a dud but in rather crowded prostate cancer drugs and treatments space like Type 2 diabetes 2. Viadur was not selling and there came a point Bayer had to stop bleeding money selling this unpopular treatment not to mention stuck with expiring pumps 3. Add to this creeping manufacturing cost and the clincher - [B]limited long-term market viability[/B] 4. Onc docs are not surgeons like endocrinologist and primary care docs 5. Difference however may be that onc drugs can sell for premium vs. generic GLP1 drugs [URL]https://www.fiercebiotech.com/biotech/marketing-of-viadur-r-leuprolide-acetate-implant-to-phase-out-by-april-2008[/URL][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Intarcia Therapeutics
>
Intarcia Therapeutics
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Intarcia Therapeutics
>
Intarcia Therapeutics
>